Search results

Order by most recent / most popular / relevance

Results: 1-10 of 25

Putative class alleges pharma statements about new drug violated securities laws

Shook Hardy & Bacon LLP
-
USA
-
May 16 2013

Aveo Pharmaceuticals, Inc. and several of its executives have been targeted in a securities class action filed in a federal court in Massachusetts

Cancer genetics IPO raises $6.9 million

Shook Hardy & Bacon LLP
-
USA
-
April 18 2013

Rutherford, New Jersey-based Cancer Genetics, Inc., an early-stage diagnostics company that develops genomic-based, oncology tests and services, has

Two Boston-area biotechs set to raise $146 million in IPOs

Shook Hardy & Bacon LLP
-
USA
-
March 21 2013

According to a news source, Enanta Pharmaceuticals, Inc. and Tetraphase Pharmaceuticals, Inc. were poised to raise a combined total of $146 million

PolyMedix expects to raise $25 million for antibiotic development

Shook Hardy & Bacon LLP
-
USA
-
March 21 2013

PolyMedix, Inc. stockholders have overwhelmingly approved a reverse stock split of the company's common stock at a ratio of up to fifty-for-one

SEC says no general duty to report financed greenhouse gas emissions

Shook Hardy & Bacon LLP
-
USA
-
March 1 2013

The U.S. Securities and Exchange Commission (SEC) has ruled that PNC Financial Services Group must allow a vote on a shareholder resolution to

Federal court allows securities fraud claims to proceed against Diamond Foods

Shook Hardy & Bacon LLP
-
USA
-
December 7 2012

A federal court in California has determined that Diamond Foods’ investors adequately pleaded knowledge, or scienter, on the part of the company and individual senior officers to allow putative class claims against them for false and misleading statements in violation of federal securities laws to proceed

DOJSEC release FCPA resource guide

Shook Hardy & Bacon LLP
-
USA
-
November 16 2012

The Department of Justice (DOJ) and Securities and Exchange Commission (SEC) have jointly issued their long-anticipated A Resource Guide to the U.S. Foreign Corrupt Practices Act

Investors seek to consolidate claims against Keurig coffee brewer maker

Shook Hardy & Bacon LLP
-
USA
-
November 9 2012

Green Mountain Coffee Roasters Inc. investors have reportedly filed a consolidated securities action against the company, claiming that they were misled about demand for Keurig and K-Cup products

Business groups challenge SEC’s conflict minerals rule

Shook Hardy & Bacon LLP
-
USA
-
November 2 2012

The National Association of Manufacturers, U.S. Chamber of Commerce and Business Roundtable have challenged a Securities and Exchange Commission (SEC) rule known as the conflict minerals rule

Study shows R&D spending in biotech has rebounded

Shook Hardy & Bacon LLP
-
USA
-
October 3 2012

Accounting and consulting group BDO USA has released a report based on information from publicly traded companies’ 10K U.S. Securities and Exchange Commission forms showing that research and development (R&D) spending in the biotechnology sector grew 5 percent in 2011, with biotech companies spending, on average, $50 million in 2011, an increase of $3 million invested in R&D in 2010

next >